Literature DB >> 34256831

Development of cavitary lung disease as a long-term complication of coronavirus disease 2019 in a young previously healthy patient: a case report.

Goar Egoryan1, Elise Hyser2, Ammar H Mushtaq2, Maria Adriana Yanez-Bello2, Daniela Patricia Trelles-Garcia2, Harvey J Friedman3,4, Guillermo Rodriguez-Nava2.   

Abstract

BACKGROUND: Cavities are frequent manifestations of a wide variety of pathological processes involving the lung. There has been a growing body of evidence of coronavirus disease 2019 leading to a cavitary pulmonary disease. CASE
PRESENTATION: A healthy 29-year-old Filipino male presented to the hospital a couple of months after convalescence from coronavirus disease 2019 with severe pleuritic chest pain, fever, chills, and shortness of breath, and was found to have a cavitary lung lesion on chest computed tomography. While conservative management alone failed to improve the patient's condition, he ultimately underwent left lung video-assisted thoracoscopic surgery decortication. Even though the surgical pathology revealed only necrosis with dense acute inflammation and granulation tissue with no microorganisms, he gradually improved with medical therapy adjunct with surgical therapy.
CONCLUSION: Documented cases of cavitary lung disease secondary to coronavirus disease 2019 have been mostly reported in the acute or subacute phase of the infection. However, clinicians should recognize this entity as a late complication of coronavirus disease 2019, even in previously healthy individuals.
© 2021. The Author(s).

Entities:  

Keywords:  COVID-19; Cavitary lung lesion; Chest computed tomography; SARS-CoV-2

Year:  2021        PMID: 34256831     DOI: 10.1186/s13256-021-02961-9

Source DB:  PubMed          Journal:  J Med Case Rep        ISSN: 1752-1947


  16 in total

Review 1.  The acute respiratory distress syndrome.

Authors:  L B Ware; M A Matthay
Journal:  N Engl J Med       Date:  2000-05-04       Impact factor: 91.245

Review 2.  Cavitary pulmonary disease.

Authors:  L Beth Gadkowski; Jason E Stout
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

3.  Rare CT feature in a COVID-19 patient: cavitation.

Authors:  Zhifeng Xu; Aizhen Pan; Huiling Zhou
Journal:  Diagn Interv Radiol       Date:  2020-07       Impact factor: 2.630

4.  Comparative efficacy and safety of immunotherapy in the first-line treatment of metastatic renal cell carcinoma: a systematic review and network meta-analysis.

Authors:  Zheran Liu; Ye Chen; Zhigong Wei; Yan He; Jingjing Wang; Xiaoli Mu; Ling He; Ruidan Li; Xiaolin Hu; Xingchen Peng
Journal:  Ann Palliat Med       Date:  2020-02-07

5.  Coronavirus Disease 2019 (COVID-19): A Systematic Review of Imaging Findings in 919 Patients.

Authors:  Sana Salehi; Aidin Abedi; Sudheer Balakrishnan; Ali Gholamrezanezhad
Journal:  AJR Am J Roentgenol       Date:  2020-03-14       Impact factor: 3.959

Review 6.  Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.

Authors:  W Joost Wiersinga; Andrew Rhodes; Allen C Cheng; Sharon J Peacock; Hallie C Prescott
Journal:  JAMA       Date:  2020-08-25       Impact factor: 56.272

7.  Lung cavitation due to COVID-19 pneumonia.

Authors:  Vijairam Selvaraj; Kwame Dapaah-Afriyie
Journal:  BMJ Case Rep       Date:  2020-07-06

8.  An unusual course of disease in two patients with COVID-19: pulmonary cavitation.

Authors:  Michael Muheim; Fabio José Weber; Patrick Muggensturm; Eva Seiler
Journal:  BMJ Case Rep       Date:  2020-09-07

Review 9.  Middle East respiratory syndrome.

Authors:  Ziad A Memish; Stanley Perlman; Maria D Van Kerkhove; Alimuddin Zumla
Journal:  Lancet       Date:  2020-03-04       Impact factor: 79.321

View more
  1 in total

1.  Biofilms possibly harbor occult SARS-CoV-2 may explain lung cavity, re-positive and long-term positive results.

Authors:  Daqian He; Chaojiang Fu; Mingjie Ning; Xianglin Hu; Shanshan Li; Ying Chen
Journal:  Front Cell Infect Microbiol       Date:  2022-09-28       Impact factor: 6.073

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.